Unique ID issued by UMIN | UMIN000038450 |
---|---|
Receipt number | R000043814 |
Scientific Title | Effects of application of the test material in healthy Japanese subjects with discomfort of knee, shoulder or waist joints: a randomized, double-blind, placebo-controlled, parallel-group trial |
Date of disclosure of the study information | 2019/10/31 |
Last modified on | 2021/05/31 13:43:50 |
Effects of application of the test material in healthy Japanese subjects with discomfort of knee, shoulder or waist joints
Effects of application of the test material in healthy Japanese subjects with discomfort of knee, shoulder or waist joints
Effects of application of the test material in healthy Japanese subjects with discomfort of knee, shoulder or waist joints: a randomized, double-blind, placebo-controlled, parallel-group trial
Effects of application of the test material in healthy Japanese subjects with discomfort of knee, shoulder or waist joints
Japan |
Healthy Japanese subjects
Not applicable | Adult |
Others
NO
To investigate the effects of the test material on knee (shoulder and/or waist) joint of healthy Japanese subjects
Efficacy
Confirmatory
Pragmatic
Not applicable
Change of the total score of Japanese Knee Osteoarthritis Measure (JKOM)
1. The change of the pre-use values between at screening (before test-material application; Scr) or the start day of the test-material application (0w) and four weeks after the start of test-material application (4w)
2. The change of the values between at Scr or 0w (pre-use) and three weeks after the start of test-material application
3. The change of the values between at Scr or 0w (pre-use) and two weeks after the start of test-material application
4. The change of the values between at Scr or 0w (pre-use) and one week after the start of test-material application
5. The change of the values between at Scr or 0w (pre-use) and three days after the start of test-material application
6. The change between pre-use and one-hour-after values at 0w
7. The change between pre-use and one-hour-after values at 4w
1. The score of visual analogue scale (VAS; JKOM)
2. The score of pain in knees (JKOM)
3. The score of stiffness in knees (JKOM)
4. The score of condition in daily life (JKOM)
5. The score of general activities (JKOM)
6. The score of health conditions (JKOM)
7. Individual items of the JKOM questionnaire
8. Customized questionnaire (the Likert scale)
*1-6 The changes calculated at the same points as the primary outcome
*7, 8 The pre-use values at Scr, 0w, three days and one, two, three, and four weeks after the start of test-material application, and one-hour-after values at 0w and 4w
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Other |
Duration: 4 weeks
Test material: Fushi-jiman (gel type)
Administration: Massage with an appropriate amount of the test material at least twice a day (when getting up and after taking a bath, for example) after cleaning the application area and wiping off moisture and sweat
Duration: 4 weeks
Test material: Placebo
Administration: Massage with an appropriate amount of the test material at least twice a day (when getting up and after taking a bath, for example) after cleaning the application area and wiping off moisture and sweat
20 | years-old | <= |
Not applicable |
Male and Female
1. Healthy Japanese adult subjects
2. Subjects who are experiencing discomfort in the knee joint
3. Subjects who are judged as eligible to participate in the study by the physician
4. Within the subjects who met the 1st to 3rd inclusion criteria, subjects who are judged in the Kellgren-Lawrence grade (KL grade) either 0 or 1 in X-ray at screening (before test-material application)
5. Within the subjects who met the 4th inclusion criteria, subjects whose total scores of JKOM are relatively high at screening (before test-material application)
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction
2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD)
3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases
4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage in daily
5. Subjects who are undergoing medical treatment of knee disease such as knee osteoarthritis
6. Subjects who are currently taking medications (including herbal medicines, compresses, and external medicines) and supplement
7. Subjects who are allergic to medicines and/or the test food related products
8. Subjects who are pregnant, lactation, or planning to become pregnant
9. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to enroll in anther clinical trial during trial period
10. Subjects who are ineligibility to participate in the study based on the evaluation of the principal physician
60
1st name | Kazuo |
Middle name | |
Last name | YAMAMOTO |
ORTHOMEDICO Inc.
CEO
112-0002
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.
03-3818-0610
kazu@orthomedico.jp
1st name | Naoko |
Middle name | |
Last name | SUZUKI |
ORTHOMEDICO Inc.
R&D Department
112-0002
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO Inc.
YASOUKOUSO.CO.,Ltd
Profit organization
Medical Corporation Seishinkai, Takara Clinic
The ethical committee of the Takara Clinic, Medical Corporation Seishinkai
9F Taisei Building, 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan.
03-5793-3623
info@takara-clinic.com
NO
医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)
2019 | Year | 10 | Month | 31 | Day |
Unpublished
Published
https://www.pieronline.jp/content/article/0386-3603/48090/1541
66
Kanai T, Takahashi Y, Takara T. The effects of "Fushi-jiman (gel type)" on knee, shoulder, or waist joint discomfort in healthy Japanese subjects: A randomized, double-blind, placebo-controlled, parallel-group trial. Pharmacol Ther. 2020; 48(9): 1541-58
2021 | Year | 05 | Month | 31 | Day |
2020 | Year | 09 | Month | 29 | Day |
Refer to the paper
Refer to the paper
Refer to the paper
Refer to the paper
Undecided
To require consultation among related companies
Completed
2019 | Year | 10 | Month | 25 | Day |
2019 | Year | 10 | Month | 25 | Day |
2019 | Year | 11 | Month | 01 | Day |
2020 | Year | 03 | Month | 28 | Day |
2019 | Year | 10 | Month | 31 | Day |
2021 | Year | 05 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043814
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |